Lineage Cell Therapeutics
LCTX
#8221
Rank
NZ$0.26 B
Marketcap
$1.40
Share price
1.22%
Change (1 day)
-34.18%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$0.10 B

According to Lineage Cell Therapeutics 's latest financial reports the company has NZ$0.10 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$98.07 M-13.44%
2022-12-31$NZ$0.11 B-14.86%
2021-12-31$NZ$0.13 B0.94%
2020-12-31$NZ$0.13 B-20.19%
2019-12-31$NZ$0.16 B20.11%
2018-12-31$NZ$0.13 B-40.54%
2017-12-31$NZ$0.23 B22.76%
2016-12-31$NZ$0.18 B68.68%
2015-12-31$NZ$0.11 B39.53%
2014-12-31$NZ$80.05 M55.66%
2013-12-31$NZ$51.42 M74.15%
2012-12-31$NZ$29.53 M-44.41%
2011-12-31$NZ$53.12 M-17.08%
2010-12-31$NZ$64.06 M321.22%
2009-12-31$NZ$15.2 M-303.05%
2008-12-31$-NZ$7.5 M88.34%
2007-12-31$-NZ$3.98 M50.21%
2006-12-31$-NZ$2.65 M820.55%
2005-12-31$-NZ$0.29 M-159.52%
2004-12-31$NZ$0.48 M-112.92%
2003-12-31$-NZ$3.74 M67.09%
2002-12-31$-NZ$2.24 M837.74%
2001-12-31$-NZ$0.24 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$0.49 B 352.19%๐Ÿ‡บ๐Ÿ‡ธ USA